Nuclera, a biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the innovator of electronic ink technology, have announced the acquisition of E Ink’s digital microfluidics unit into the newly formed US subsidiary of Nuclera. The company said in a statement, “Combining the technologies of the two companies will enable the delivery…